Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Biotechnology
$10.86
-4.02%
Mkt Cap $767.61M
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$34.75
Range $27.00 – $40.00
Implied Upside
+220.1%
Consensus $34.75 vs current $10.86
NASDAQ·Healthcare·Biotechnology
$10.86
-4.02%
Mkt Cap $767.61M
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$34.75
Range $27.00 – $40.00
+220.1%
Consensus $34.75 vs current $10.86